Reviewed,
UniProtKB/Swiss-Prot Q96B36 (AKTS1_HUMAN)
Last modified
December 15, 2009.
Version 57.
History...
Clusters with 100%,
90%,
50% identity |
Documents (4) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Proline-rich AKT1 substrate 1 Alternative name(s): 40 kDa proline-rich AKT substrate | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Complete proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 256 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is not processed. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | Subunit of mTORC1, which regulates cell growth and survival in response to nutrient and hormonal signals. mTORC1 is activated in response to growth factors or amino-acids. Amino-acid-signaling to mTORC1 is mediated by Rag GTPases, which cause amino-acid-induced relocalization of mTOR within the endomembrane system. Growth factor-stimulated mTORC1 activation involves a AKT1-mediated phosphorylation of TSC1-TSC2, which leads to the activation of the RHEB GTPase that potently activates the protein kinase activity of mTORC1. Activated mTORC1 up-regulates protein synthesis by phosphorylating key regulators of mRNA translation and ribosome synthesis. mTORC1 phosphorylates EIF4EBP1 and releases it from inhibiting the elongation initiation factor 4E (eiF4E). mTORC1 phosphorylates and activates S6K1 at 'Thr-389', which then promotes protein synthesis by phosphorylating PDCD4 and targeting it for degradation. Within mTORC1, AKT1S1 negatively regulates mTOR activity in a manner that is dependent on its phosphorylation state and binding to 14-3-3 proteins. Inhibits RHEB-GTP-dependent mTORC1 activation. Substrate for AKT1 phosphorylation, but can also be activated by AKT1-independent mechanisms. May also play a role in nerve growth factor-mediated neuroprotection. Ref.6 Ref.8 Ref.9 |
| Subunit structure | Part of the mammalian target of rapamycin complex 1 (mTORC1) which contains FRAP1, LST8, RAPTOR and AKT1S1. mTORC1 binds to and is inhibited by FKBP12-rapamycin. Interacts directly with RPTOR. The phosphorylated form interacts with 14-3-3 proteins. Ref.8 Ref.5 |
| Subcellular location | Cytoplasm › cytosol By similarity. Note: Found in the cytosolic fraction of the brain By similarity. |
| Tissue specificity | Widely expressed with highest levels of expression in liver and heart. Expressed at higher levels in cancer cell lines (e.g. A549 and HeLa) than in normal cell lines (e.g. HEK293). Ref.6 Ref.5 Ref.1 |
| Post-translational modification | Phosphorylated by AKT1. Phosphorylation relieves inhibitory function on mTORC1. Ref.5 Ref.7 Ref.10 Ref.11 |
Ontologies
| Keywords | |
|---|---|
| Cellular component | Cytoplasm |
| Coding sequence diversity | Alternative splicing Polymorphism |
| PTM | Phosphoprotein |
| Technical term | Complete proteome |
| Gene Ontology (GO) | |
| Biological process | negative regulation of TOR signaling pathway Ref.8 Inferred from direct assay. Source: UniProtKB negative regulation of cell size Ref.8Inferred from direct assay. Source: UniProtKB negative regulation of protein kinase activity Ref.8Inferred from direct assay. Source: UniProtKB neuroprotectionInferred from sequence or structural similarity. Source: UniProtKB regulation of survival gene product expressionInferred from sequence or structural similarity. Source: UniProtKB |
| Cellular component | cytosolic part Inferred from sequence or structural similarity. Source: UniProtKB |
| Molecular function | protein binding Ref.8 Inferred from physical interaction. Source: UniProtKB |
| Complete GO annotation... | |
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 Ref.4 Ref.1 (identifier: Q96B36-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 Ref.4 (identifier: Q96B36-2) The sequence of this isoform differs from the canonical sequence as follows: 1-130: Missing. | ||||||
| Note: No experimental confirmation available. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 256 | 256 | Proline-rich AKT1 substrate 1 | PRO_0000253446 | |||||
Regions | |||||||||
| Compositional bias | 35 – 43 | 9 | Poly-Pro | ||||||
| Compositional bias | 77 – 96 | 20 | Pro-rich | ||||||
Amino acid modifications | |||||||||
| Modified residue | 88 | 1 | Phosphoserine Ref.10 Ref.11 | ||||||
| Modified residue | 92 | 1 | Phosphoserine Ref.10 Ref.11 | ||||||
| Modified residue | 116 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 183 | 1 | Phosphoserine Ref.7 Ref.11 | ||||||
| Modified residue | 198 | 1 | Phosphothreonine | ||||||
| Modified residue | 202 | 1 | Phosphoserine Ref.11 | ||||||
| Modified residue | 203 | 1 | Phosphoserine Ref.11 | ||||||
| Modified residue | 211 | 1 | Phosphoserine Ref.11 | ||||||
| Modified residue | 212 | 1 | Phosphoserine Ref.11 | ||||||
| Modified residue | 246 | 1 | Phosphothreonine; by PKB/AKT1 Ref.5 Ref.7 Ref.11 | ||||||
Natural variations | |||||||||
| Alternative sequence | 1 – 130 | 130 | Missing in isoform 2. Ref.4 | VSP_052182 | |||||
| Natural variant | 47 | 1 | A → P: dbSNP rs17850191. Ref.4 | VAR_028239 | |||||
Experimental info | |||||||||
| Mutagenesis | 246 | 1 | T → A: Suppresses S6K1 phosphorylation by mTORC1. Ref.9 | ||||||
| Sequence conflict | 108 | 1 | D → G in BAB70937. Ref.1 | ||||||
| Sequence conflict | 196 | 1 | K → M in BAB70937. Ref.1 | ||||||
| Sequence conflict | 233 | 1 | T → A in BAB70937. Ref.1 | ||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed: 14702039] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). Tissue: Prostate and Synovium. |
| [2] | "The DNA sequence and biology of human chromosome 19." Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S., Carrano A.V. Lucas S.M.Nature 428:529-535(2004) [PubMed: 15057824] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [3] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [4] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), VARIANT PRO-47. Tissue: Brain, Eye and Skin. |
| [5] | "Identification of a proline-rich Akt substrate as a 14-3-3 binding partner." Kovacina K.S., Park G.Y., Bae S.S., Guzzetta A.W., Schaefer E., Birnbaum M.J., Roth R.A. J. Biol. Chem. 278:10189-10194(2003) [PubMed: 12524439] [Abstract] Cited for: INTERACTION WITH 14-3-3, TISSUE SPECIFICITY, PHOSPHORYLATION AT THR-246. |
| [6] | "Expression of proline-rich Akt-substrate PRAS40 in cell survival pathway and carcinogenesis." Huang B., Porter G. Acta Pharmacol. Sin. 26:1253-1258(2005) [PubMed: 16174443] [Abstract] Cited for: FUNCTION, TISSUE SPECIFICITY. |
| [7] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed: 17081983] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-183 AND THR-246, MASS SPECTROMETRY. Tissue: Epithelium. |
| [8] | "PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase." Sancak Y., Thoreen C.C., Peterson T.R., Lindquist R.A., Kang S.A., Spooner E., Carr S.A., Sabatini D.M. Mol. Cell 25:903-915(2007) [PubMed: 17386266] [Abstract] Cited for: FUNCTION, IDENTIFICATION IN THE TORC1 COMPLEX, INTERACTION WITH RPTOR. |
| [9] | "Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40." Vander Haar E., Lee S.-I., Bandhakavi S., Griffin T.J., Kim D.-H. Nat. Cell Biol. 9:316-323(2007) [PubMed: 17277771] [Abstract] Cited for: FUNCTION, IDENTIFICATION IN THE TORC1 COMPLEX, MUTAGENESIS OF THR-246. |
| [10] | "Global proteomic profiling of phosphopeptides using electron transfer dissociation tandem mass spectrometry." Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A. Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007) [PubMed: 17287340] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-88 AND SER-92, MASS SPECTROMETRY. |
| [11] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed: 18669648] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-88; SER-92; SER-183; SER-202; SER-203; SER-211; SER-212 AND THR-246, MASS SPECTROMETRY. |
| [12] | "Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach." Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S. Anal. Chem. 81:4493-4501(2009) [PubMed: 19413330] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-183; THR-198; SER-202; SER-203; SER-211; SER-212 AND THR-246, MASS SPECTROMETRY. |
| [13] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed: 19690332] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-88; SER-92; SER-183; SER-202; SER-212 AND THR-246, MASS SPECTROMETRY. Tissue: T-cell. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| AK055511 mRNA. Translation: BAB70937.1. AK092610 mRNA. Translation: BAG52583.1. AK316603 mRNA. Translation: BAG38190.1. AC118341 Genomic DNA. No translation available. CH471177 Genomic DNA. Translation: EAW52568.1. BC000031 mRNA. Translation: AAH00031.2. Different initiation. BC007416 mRNA. Translation: AAH07416.1. BC015562 mRNA. Translation: AAH15562.1. BC016043 mRNA. Translation: AAH16043.1. BC051844 mRNA. Translation: AAH51844.1. | |
| IPI | IPI00306195. IPI00549786. |
| RefSeq | NP_001092102.1. NP_001092103.1. NP_115751.2. |
| UniGene | Hs.515542 |
3D structure databases | |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | Q96B36. 5 interactions. |
| STRING | Q96B36. |
PTM databases | |
| PhosphoSite | Q96B36. |
Proteomic databases | |
| PRIDE | Q96B36. |
Genome annotation databases | |
| Ensembl | ENST00000344175; ENSP00000341698; ENSG00000204673; Homo sapiens. [Genome view] ENST00000391831; ENSP00000375707; ENSG00000204673; Homo sapiens. [Genome view] ENST00000391832; ENSP00000375708; ENSG00000204673; Homo sapiens. [Genome view] ENST00000391833; ENSP00000375709; ENSG00000204673; Homo sapiens. [Genome view] ENST00000391834; ENSP00000375710; ENSG00000204673; Homo sapiens. [Genome view] ENST00000391835; ENSP00000375711; ENSG00000204673; Homo sapiens. [Genome view] |
| GeneID | 84335. |
| KEGG | hsa:84335. |
| UCSC | uc002pql.2. human. |
Organism-specific databases | |
| CTD | 84335. |
| GeneCards | GC19M055073. |
| HGNC | HGNC:28426. AKT1S1. |
| HPA | CAB021903. |
| MIM | 610221. gene. |
| PharmGKB | PA134943587. |
| GenAtlas | Search... |
Phylogenomic databases | |
| HOVERGEN | Q96B36. |
| InParanoid | Q96B36. |
| OrthoDB | EOG94XN2H. |
Enzyme and pathway databases | |
| Pathway_Interaction_DB | pi3kciaktpathway. Class I PI3K signaling events mediated by Akt. |
| Reactome | REACT_11061. Signalling by NGF. |
Gene expression databases | |
| ArrayExpress | Q96B36. |
| Bgee | Q96B36. |
| CleanEx | HS_AKT1S1. |
| Genevestigator | Q96B36. |
| GermOnline | ENSG00000204673. Homo sapiens. |
Family and domain databases | |
| ProtoNet | Search... |
Other Resources | |
| NextBio | 74105. |
| SOURCE | Search... |
Entry information
| Entry name | AKTS1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q96B36 Secondary accession number(s): A8MTQ1 Q9BWR5 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 19 Human chromosome 19: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |

Clusters with


